-

Valor CEO Named One of The Best CEO’s to Watch 2021

Valor Compounding Pharmacy’s Rick Niemi, Founder and CEO makes CIO Bulletin’s annual best CEO list.

BERKELEY, Calif.--(BUSINESS WIRE)--After The Silicon Review published their list of the 30 Best CEO's of the Year 2021, which honored Rick Niemi as one of the top 30 CEO’s in 2021, CIO Bulletin has named Niemi among the 10 Best CEO’s to Watch 2021. Valor Compounding Pharmacy, of which Niemi is Founder and CEO, furthers its mission to bring peace of mind and a greater awareness of compounded prescription medication options to patients throughout the United States.

"Thank you, CIO Bulletin, for this story on Valor," says Rick Niemi, Founder and CEO at Valor Compounding Pharmacy, "and the information shared about our role in helping people live their best lives."

In addition to CIO Bulletin's ranking of Niemi as one of the Top 10 Best CEO's to Watch 2021, Valor also celebrates recent accomplishments, including:

"It's important we create a greater awareness of what we do at Valor and how we might help. It's not just about making and shipping high-quality compounded prescriptions nationwide. Earning trust and confidence, both in and out of the prescriber's office, is key to our success." Niemi continues, “The foundation of earned trust begins with the accreditations and quality assurance accomplishments, led by our Chief Pharmacy Officer, Christine Stephanos. The trust we earn complements the unique way we work with providers and their member patients throughout the country. Sherine Khalil, Valor's Chief Business Officer, guided the business to achieve LegitScript’s Healthcare Certification status, ensuring Valor meets standards for the legality, safety, and transparency as a pharmacy company," Rick concludes.

Valor Compounding Pharmacy recognizes the need for patients to have predictable and dependable compounded medications delivered directly to their front door. The scope of service includes flat-rate pricing, free shipping, and fast turnaround. CIO Bulletin recognizes Valor CEO Niemi, with the entire Valor team, as the prescriber's choice in customized compounded medications. Click here to read the full article about Valor’s mission.

About Valor Compounding Pharmacy:

Valor Compounding Pharmacy™, Inc. is a multi-state licensed 503A facility housing both sterile and non-sterile laboratories, located in Berkeley, CA. PCAB accredited, Valor is a specialized pharmacy that makes custom medications to meet the unique needs of the individual patient. Our goal is to reinvent pharmacy from a reactive vendor to a proactive partner in patient health care. We do that by optimizing turnaround time, being data-driven, and reducing patient anxiety. Our focus is on non-sterile and sterile, hazardous and non-hazardous compounded medication, and we work with a network of providers, patients, health systems/institutions, and research scientists in multiple states in the United States.

More about CIO Bulletin:

CIO Bulletin is an interactive, preeminent platform focused on leadership serving as a resource center of information on Business and IT leaders and their entrepreneurial ventures. From celebrating innovation to identifying best practices and providing a marketplace for today’s CIOs and other tech decision-makers, CIO Bulletin keeps its readers informed about how tech giants, governments, and consumers are developing organizational innovation in Business and IT.

Contacts

Valor Compounding Pharmacy
Marketing & Media
Lucy Casey
855.554.2889
marketing@vcprx.com

Valor Compounding Pharmacy


Release Summary
Valor Compounding Pharmacy’s Rick Niemi, Founder and CEO makes CIO Bulletin’s annual best CEO list.
Release Versions

Contacts

Valor Compounding Pharmacy
Marketing & Media
Lucy Casey
855.554.2889
marketing@vcprx.com

More News From Valor Compounding Pharmacy

As Health Systems Rethink In-House Compounding, Valor Compounding Pharmacy Highlights How Outsourcing Low-Volume Prescriptions Saves Risk, Time, and Money

BERKELEY, Calif.--(BUSINESS WIRE)--As healthcare systems face increasing regulatory scrutiny and financial pressure, many are re-evaluating the value of maintaining in-house compounding operations for outpatient prescriptions. The reality: compounded medications serve a very small percentage of the patient population, yet require disproportionately high investment, compliance oversight, and staff time to sustain safety. Valor Compounding Pharmacy, a multi-state licensed 503a pharmacy headquarte...

Valor Compounding Pharmacy Announces Call for New Partnerships with Medical Practices and Hospital Systems

BERKELEY, Calif.--(BUSINESS WIRE)--Valor is a specialized pharmacy that prepares custom medications to meet the unique needs of the individual patient....

2022 Year-in-Review with Valor Compounding Pharmacy

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy closes the year achieving growth in multiple areas throughout its business while continuing to exceed customer satisfaction standards. Valor has expanded its state-of-the-art 503A facility that holds both sterile and non-sterile laboratories to a 6,421 square feet workspace to support its growing customer demand. After completing the expansion in the 3rd quarter of 2022, the compounding pharmacy relaunched its sterile operations, hav...
Back to Newsroom